| 产品详情 |
| Edit |   |
|---|
| Product Name | GSK 2837808A |
|---|
| Description | Potent, selective lactate dehydrogenase A (LDHA) inhibitor (IC50 values are 1.9 and 14 nM for LDHA and LDHB respectively). Inhibits lactate production in selected cancer cell lines. Reduces glucose uptake and enhances mitochondrial oxygen consumption in Snu398 hepatocellular carcinoma cells. Inhibits proliferation and induces apoptosis in Snu398 cells. Inhibits transcription of histone 2B (H2B) gene in HCT116 and NCM460 cells. Cell permeable. Purity 98%. MW (observed): 649.62 |
|---|
| Size | 10 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | 3-[[3-[(Cyclopropylamino)sulfonyl]-7-(2,4-dimethoxy-5-pyrimidinyl)-4-quinolinyl]amino]-5-(3,5-difluorophenoxy)benzoic acid |
|---|
| Gene, Accession, CAS # | CAS: 1445879-21-9 |
|---|
| Catalog # | 5189/10 |
|---|
| Price | |
|---|
| Order / More Info | GSK 2837808A from TOCRIS BIOSCIENCE
|
|---|
| Product Specific References | PubMed: 28106079, 28257841, 28263970 |
|---|
| 产品资料 |
|
|